SLC7A5 and central nervous system cancer: LAT1 overexpression has been widely reported in gliomas, with quantitative PCR analyses revealing a 40- to 400-fold increase in LAT1 expression in GBM compared to normal brain tissue, correlating with tumor grade [195].